Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Operating Leases (2023 - 2025)

Metagenomi (MGX) has disclosed Operating Leases for 3 consecutive years, with $34.6 million as the latest value for Q4 2025.

  • Quarterly Operating Leases fell 13.82% to $34.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $34.6 million through Dec 2025, down 13.82% year-over-year, with the annual reading at $34.6 million for FY2025, 13.82% down from the prior year.
  • Operating Leases for Q4 2025 was $34.6 million at Metagenomi, down from $36.1 million in the prior quarter.
  • The five-year high for Operating Leases was $44.8 million in Q4 2023, with the low at $34.6 million in Q4 2025.
  • Average Operating Leases over 3 years is $40.0 million, with a median of $40.2 million recorded in 2024.
  • The sharpest move saw Operating Leases dropped 10.3% in 2024, then fell 13.82% in 2025.
  • Over 3 years, Operating Leases stood at $44.8 million in 2023, then decreased by 10.3% to $40.2 million in 2024, then fell by 13.82% to $34.6 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $34.6 million, $36.1 million, and $37.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.